Groundbreaking research at the Hackensack Meridian Center for Discovery and Innovation is paving the way for an exhaled-breath test for lung cancer detection.
- Research conducted by Olivier Loudig, Ph.D., at the Hackensack Meridian Center for Discovery and Innovation is focused on developing an exhaled-breath test for early detection of lung diseases, including lung cancer.
- Dr. Loudig and his team have successfully identified lung biomarkers from human breath and developed animal models to potentially detect metastatic lung tumors through non-invasive means.
- The research is geared towards lowering the threshold for early detection of lung cancer, providing hope for effective intervention.
- Dr. Loudig’s work involves capturing and analyzing extracellular vesicles released by cells, especially cancer cells, to identify disease markers for early diagnosis of various cancers.
- Their cutting-edge technology, EV-CATCHER, has shown promise in detecting lung cancer through exhaled breath samples, paving the way for a revolutionary approach to diagnosing and monitoring lung diseases.
Source link
Pulmonary Medicine, Oncology